In vitro effect of the iron chelator deferiprone on the antimicrobial susceptibility and biofilms of Burkholderia pseudomallei

References

• Ammendola S, Secli V, Pacello F, Bortolami M, Pandolfi F, Messore A, Di Santo R, Scipione L, Battistoni A. 2021. Salmonella Typhimurium and Pseudomonas aeruginosa respond differently to the Fe chelator deferiprone and to some novel deferiprone derivatives. Int J Mol Sci. 22:10217. doi:10.3390/ijms221910217
   PubMed Web of Science ®Google Scholar
• Bandeira TJPG, Moreira CA, Brilhante RSN, Castelo-Branco DSCM, Neto MP, Cordeiro RA, Rodrigues TJS, Rocha MFG, Sidrim JJC. 2013. In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei. Antimicrob Agents Chemother. 57:5771–5773. doi:10.1128/AAC.00721-1310.1128/AAC.00721-13
   PubMed Web of Science ®Google Scholar
• Benoit TJ, Blaney DD, Doker TJ, Gee JE, Elrod MG, Rolim DB, Inglis TJJ, Hoffmaster AR, Bower WA, Walke, HT, T. 2015. A review of melioidosis cases in the Americas. Am J Trop Med Hyg. 93:1134–1139. doi:10.4269/ajtmh.15-0405
   PubMed Web of Science ®Google Scholar
• Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P. 2005. Iron availability influences aggregation, biofilm, adhesion, and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol. 18:661–670. doi:10.1177/039463200501800407
   PubMed Web of Science ®Google Scholar
• Brilhante RSN, Bandeira TJPG, Cordeiro RA, Grangeiro TB, Lima RAC, Ribeiro JF, Castelo-Branco DSCM, Rodrigues JLN, Coelho ICB, Magalhães FG, et al. 2012a. Clinical-epidemiological features of 13 cases of melioidosis in Brazil. J Clin Microbiol. 50:3349–3352. doi:10.1128/JCM.01577-12
   PubMed Web of Science ®Google Scholar
• Brilhante RSN, Costa AC, Pereira VS, Fernandes MR, Oliveira JS, Rodrigues AM, Camargo ZP, Pereira-Neto WA, Sidrim JJC, Rocha MFG. 2020. Antifungal activity of deferiprone and EDTA against Sporothrix spp.: effect on planktonic growth and biofilm formation. Med Mycol. 59:537–544. doi:10.1093/mmy/myaa073
   Web of Science ®Google Scholar
• Brilhante RSN, Valente LGA, Rocha MFG, Bandeira TJPG, Cordeiro RA, Lima RAC, Leite JJG, Ribeiro JF, Pereira JF, Castelo-Branco DSCM, et al. 2012b. Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei. Antimicrob Agents Chemother. 56:2198–2200. doi:10.1128/AAC.05885-1110.1128/AAC.05885-1
   PubMed Web of Science ®Google Scholar
• Butt A, Halliday N, Williams P, Atkins HS, Bancroft GJ, Titball RW. 2016. Burkohlderia pseudomallei kynB plays a role in AQ production, biofilm formation, bacterial swarming, and persistence. Res Microbiol. 167:159–167. doi:10.1016/j.resmic.2015.11.002
   PubMed Web of Science ®Google Scholar
• Castelo-Branco DSCM, Riello GB, Vasconcelos DC, Guedes GMM, Serpa R, Bandeira TJPG, Monteiro AJ, Cordeiro RA, Rocha MFG, Sidrim JJC, et al. 2016. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. J Appl Microbiol. 120:600–606. doi:10.1111/jam.2016.120.issue-310.1111/jam.2016.120.issue-3
   PubMed Web of Science ®Google Scholar
• Chan GCF, Chan S, Ho PL, Ha SY. 2009. Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients. Hemoglobin. 33:352–360. doi:10.3109/03630260903211888
   PubMed Web of Science ®Google Scholar
• Cheng AC, Dance DAB, Currie BJ. 2005. Bioterrorism, glanders and melioidosis. Euro Surveill. 10: e 1–2.
   Google Scholar
• CLSI. 2018. Performance standards for antimicrobial susceptibility testing: standards. CLSI document M100-S28. Wayne (PA): Clinical and Laboratory Standards Institute.
   Google Scholar
• Coraça-Huber DC, Dichtl S, Steixner S, Nogler M, Weiss G. 2018. Iron chelation destabilizes bacterial biofilms and potentiates the antimicrobial activity of antibiotics against coagulase-negative Staphylococci. Pathog Dis. 76:1–8. doi:10.1093/femspd/fty052
   Web of Science ®Google Scholar
• Duangurai T, Indrawattana N, Pumirat P. 2018. Burkholderia pseudomallei adaptation for survival in stressful conditions. Biomed Res Int. 2018:3039106. doi:10.1155/2018/3039106
   PubMed Web of Science ®Google Scholar
• Ezraty B, Barras F. 2016. The ‘liaisons dangereuses’ between iron and antibiotics. FEMS Microbiol Rev. 40:418–435. doi:10.1093/femsre/fuw004
   PubMed Web of Science ®Google Scholar
• Faure ME, Cilibrizzi A, Abbate V, Bruce KD, Hider RC. 2021. Effect of iron chelation on anti-pseudomonal activity of doxycycline. Int J Antimicrob Agents. 58:106438. doi:10.1016/j.ijantimicag.2021.106438
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol. 8:623–633. doi:10.1038/nrmicro2415
   PubMed Web of Science ®Google Scholar
• Gerhardy B, Simpson G. 2013. Melioidosis and idiopathic pulmonar hemosiderosis: a cast-iron case. Respirol Case Rep. 1:46–47. doi:10.1002/rcr2.25
   PubMedGoogle Scholar
• Gokarn K, Pal RB. 2018. Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria. Infect Drug Resist. 11:61–75. doi:10.2147/IDR.S148602
   PubMed Web of Science ®Google Scholar
• Grenier D, Huot MP, Mayrand D. 2000. Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics. Antimicrob Agents Chemother. 44:763–766. doi:10.1128/AAC.44.3.763-766.2000
   PubMed Web of Science ®Google Scholar
• Harrison F, Buckling A. 2009. Siderophore production and biofilm formation as linked social traits. ISME J. 3:632–634. doi:10.1038/ismej.2009.9
   PubMed Web of Science ®Google Scholar
• Hengzhuang W, Ciofu O, Yang L, Wu H, Song Z, Oliver A, Hoiby N. 2013. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 57:196–204. doi:10.1128/AAC.01393-12
   PubMed Web of Science ®Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.011
   PubMed Web of Science ®Google Scholar
• Houshmandyar S, Eggleston IM, Bolhuis A. 2021. Biofilm-specific uptake of a 4-pyridone-based iron chelator by Pseudomonas aeruginosa. Biometals. 34:315–328. doi:10.1007/s10534-020-00281-x
   PubMed Web of Science ®Google Scholar
• Huang MH, Wu H, Zhou XJ, Cao QF, Wang XM. 2021. Evaluation of the antibacterial activity of Piperacillin–tazobactam against Burkholderia pseudomallei in vitro. Research Square. doi:10.21203/rs.3.rs-322273/v1
   Google Scholar
• Ibrahim AS, Edwards JE, Jr, Fu Y, Spellberg B. 2006. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 58:1070–1073. doi:10.1093/jac/dkl350
   PubMed Web of Science ®Google Scholar
• Kamjumphol W, Chareonsudjai S, Chareonsudjai P, Wongratanacheewin S, Taweechaisupapong S. 2013. Environmental factors affecting Burkholderia pseudomallei biofilm formation. Southeast Asian J Trop Med Public Health. 44:72–81. PMID23682440.
   PubMed Web of Science ®Google Scholar
• Kang D, Kirienko NV. 2018. Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa. J Microbiol. 56:449–457. doi:10.1007/s12275-018-8114-3
   PubMed Web of Science ®Google Scholar
• Khosravi Y, Vellasamy KM, Mariappan V, Ng S-L, Vadivelu J. 2014. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients. Sci. World J. 2014:1–9. doi:10.1155/2014/132971.
   Google Scholar
• Kim CM, Shin SH. 2009. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci. J Korean Med Sci. 24:289–295. doi:10.3346/jkms.2009.24.2.289
   PubMed Web of Science ®Google Scholar
• Lesic B, Foulon J, Carniel E. 2002. Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother. 46:1741–1745. doi:10.1128/AAC.46.6.1741-1745.2002
   PubMed Web of Science ®Google Scholar
• Ma L, Gao Y, Maresso AW. 2015. Escherichia coli free radical-base killing mechanism driven by a unique combination of iron restriction and certain antibiotics. J Bacteriol. 197:3708–3719. doi:10.1128/JB.00758-15
   PubMed Web of Science ®Google Scholar
• Nazik H, Penner JC, Ferreira JÁ, Haagensen JAJ, Cohen K, Spormann AM, Martinez M, Chen V, Hsu JL, Clemons KV, et al. 2015. Effects of iron chelators on the formation and development of Aspergillus fumigatus biofilm. Antimicrob Agents Chemother. 59:6514–6520. doi:10.1128/AAC.01684-15
   PubMed Web of Science ®Google Scholar
• Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 57:677–701. doi:10.1146/annurev.micro.57.030502.090720
   PubMed Web of Science ®Google Scholar
• Pibalpakdee P, Wongratanacheewin S, Taweechaisupapong S, Niumsup PR. 2012. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms. Int J Antimicrob Agents. 39:356–359. doi:10.1016/j.ijantimicag.2011.12.010
   PubMed Web of Science ®Google Scholar
• Ramalingam K, Lee V. 2019. Synergistic effects of nanoemulsion and deferiprone (1,2 dimethyl-3-hydroxypyrid-4-one) on multi-drug resistant Acinetobacter baumannii. Nano BioMed ENG. 11:226–237. doi:10.5101/nbe.v11i3.p226-237
   Google Scholar
• Richter K, Thomas N, Zhang G, Prestidge CA, Coenye T, Wormald PJ, Vreugde S. 2017. Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants. Front Cell Infect Microbiol. 7:280. doi:10.3389/fcimb.2017.00280
   PubMed Web of Science ®Google Scholar
• Saha R, Saha N, Donofrio RS, Bestervelt LL. 2013. Microbial siderophores: a mini review. J Basic Microbiol. 53:303–317. doi:10.1002/jobm.201100552
   PubMed Web of Science ®Google Scholar
• Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. 2010. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 5:e9196. doi:10.1371/journal.pone.0009196
   PubMed Web of Science ®Google Scholar
• Scott C, Arora G, Dickson K, Lehmann C. 2021. Iron chelation in local infection. Molecules. 26:189. doi:10.3390/molecules26010189
   PubMed Web of Science ®Google Scholar
• Sidrim JJC, Ocadaque CJ, Amando BR, Guedes GMM, Costa CL, Brilhante RSN, Cordeiro RA, Rocha MFG, Castelo-Branco DSCM. 2020. Rhamnolipid enhances Burkholderia pseudomallei biofilm susceptibility, disassembly and production of virulence factors. Future Microbiol. 15:1109–1121. doi:10.2217/fmb-2020-0010
   PubMedGoogle Scholar
• Sidrim JJC, Vasconcelos DC, Riello GB, Guedes GMM, Serpa R, Bandeira TJPG, Monteiro AJ, Cordeiro RA, Castelo-Branco DSCM, Rocha MFG, et al. 2017. Promethazine improves antibiotic efficacy and disrupts biofilms of Burkholderia pseudomallei. Biofouling. 33:88–97. doi:10.1080/08927014.2016.1262846
   PubMed Web of Science ®Google Scholar
• Singh PK. 2004. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals. 17:267–270. doi:10.1023/b:biom.0000027703.77456.27
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lamont IL, Anderson GJ, Reid DW. 2013. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis. Eur Respir J. 42:1723–1736. doi:10.1183/09031936.00124012
   PubMed Web of Science ®Google Scholar
• Tajudin SM, Besari AM, Ismail N, Hassan SA, Zaidah AR. 2019. Melioidosis presented as severe acute cholangitis: A rare presentation. Int J Case Rep Images. 10:101049Z01ST2019. doi:10.5348/101049Z01ST2019CR
   Google Scholar
• Thompson MG, Corey BW, Si Y, Craft DW, Zurawski DV. 2012. Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob Agents Chemother. 56:5419–5421. doi:10.1128/AAC.01197-12
   PubMed Web of Science ®Google Scholar
• Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F. 2013. The dual personality of iron chelators: growth inhibitors or promoters? Antimicrob Agents Chemother. 57:2432–2433. doi:10.1128/AAC.02529-12
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Van Der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol. 4:272–282. doi:10.1038/nrmicro1385
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, Limmathurotsakul D. 2018. Melioidosis. Nat Rev Dis Primers. 4:17107. doi:10.1038/nrdp.2017.107
   PubMed Web of Science ®Google Scholar
• Yu S, Wei Q, Zhao T, Guo Y, Ma LZ. 2016. A survival strategy for Pseudomonas aeruginosa that uses exopolysaccharides to sequester and store iron to stimulate Psl-dependent biofilm formation. Appl Environ Microbiol. 82:6403–6413. doi:10.1128/AEM.01307-16
   PubMed Web of Science ®Google Scholar
• Zhou YJ, Zhang MX, Hider RC, Zhou T. 2014. In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin. FEMS Microbiol Lett. 355:124–130. doi:10.1111/1574-6968.12465
   PubMed Web of Science ®Google Scholar